financetom
Business
financetom
/
Business
/
HubSpot Upmarket Momentum Accelerates as Multi-Hub Adoption Drives Growth, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HubSpot Upmarket Momentum Accelerates as Multi-Hub Adoption Drives Growth, RBC Says
Nov 9, 2024 12:26 PM

12:51 PM EST, 11/07/2024 (MT Newswires) -- HubSpot ( HUBS ) "upmarket momentum accelerated," in Q3 balancing the impact of a pricing model shift on smaller customer revenues, RBC said in a note Thursday.

"ASRPC headwinds from customers starting at lower initial price points persisted in Q3, but were offset by upmarket momentum, as well as overall higher volume of customers," RBC said in the note.

HubSpot's ( HUBS ) upmarket momentum gained pace in Q3, with strong traction from enterprise clients and multi-hub deals offsetting macro pressures, RBC said.

The company reported a "solid beat-and-raise quarter", with revenue exceeding consensus by around 4%, up 20% year-over-year, the firm said.

HubSpot ( HUBS ) reported Q3 non-GAAP net income of $2.18 per diluted share on revenue of $669.7 million late on Wednesday, compared with analyst estimates of $1.91 and $647.3 million, respectively.

"Upside in revenue, billings, and operating margin were roughly inline with recent trends, as the macro remained unchanged," RBC said in the note. "All in, HubSpot ( HUBS ) continues to maneuver macro challenges."

The company raised 2024 revenue guidance by $28 million RBC noted, adding that "this further de-risks Q4, a seasonally strong quarter."

RBC raised its price target on HubSpot's ( HUBS ) stock to $750 from $700 and maintained an outperform rating.

HubSpot ( HUBS ) shares rose by more than 9% in recent trading.

Price: 650.89, Change: +53.10, Percent Change: +8.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved